Rydex Biotechnology Fund Class Investor (RYOIX) Research
The Rydex Biotechnology Fund, Class Investor, aims to achieve capital growth for its shareholders. Under normal circumstances, the fund dedicates a significant majority – at least 80% – of its total net assets to common stocks of biotechnology enterprises that are listed on U.S. exchanges. Furthermore, it incorporates derivative instruments, principally comprising futures agreements and options tied to individual securities, other futures contracts, and broad stock market indices. A notable component of its investment approach is the discretion to allocate a considerable portion of its holdings to biotechnology companies characterized by small to medium market capitalizations. This fund maintains a non-diversified portfolio structure.
Market snapshot
- Symbol
- RYOIX
- Price
- $81.73
- Day change
- +0.06%
- Market cap
- $86.2M
- 52-week range
- 62.94-86.08
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Eventide Exponential Technologies Fund Class N (ETNEX)
- Frontier MFG Core Infrastructure Fund Service Class (FCIVX)
- Frontier MFG Core Infrastructure Fund Institutional Class (FMGIX)
- F/m Investments Large Cap Focused Fund - Investor Class (IAFMX)
- Janus Henderson Small-Mid Cap Value Fund - T Shares (JSVTX)
- Janus Henderson Small-Mid Cap Value Fund - I Shares (JVSIX)
- North Star Dividend Fund Class I (NSDVX)
- Rydex Electronics Inv (RYSIX)
Open Rydex Biotechnology Fund Class Investor (RYOIX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.